Modifi Biosciences Acquired by Merck

Modifi Biosciences, Inc. (“Modifi Biosciences”), a leader in the development of direct DNA modification enabled cancer therapeutics, announces that the company has been acquired by Merck, known as MSD outside of the United States and Canada. Under the terms of the agreement Merck, through a subsidiary, has acquired all outstanding shares of Modifi Biosciences for $30 million upfront. Modifi Biosciences shareholders are also eligible to receive potential milestone payments totaling up to $1.3 billion.

Read the full article: Modifi Biosciences Acquired by Merck //

Source: https://www.globenewswire.com/news-release/2024/10/23/2967652/0/en/Modifi-Biosciences-Acquired-by-Merck.html

Scroll to Top